🧪 Hypotheses

therapeutic 0.97

Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to restore hippocampal gamma oscillations v

🧬 SST 🏥 alzheimers 📖 55🏛 3

✅ 0.00 ✨ 0.60 💥 0.00

## Mechanistic Overview...

therapeutic 0.96

Closed-loop optogenetic targeting PV interneurons to restore theta-gamma coupling and prevent amyloid-induced synaptic d

🧬 PVALB 🏥 alzheimers 📖 61🏛 3

✅ 0.00 ✨ 0.50 💥 0.00

## Mechanistic Overview...

therapeutic 0.96

Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to prevent tau propagation and restore ento

🧬 SST 🏥 alzheimers 📖 50🏛 3

✅ 0.54 ✨ 0.85 💥 0.74

## Mechanistic Overview...

therapeutic 0.95

Gamma entrainment therapy to restore hippocampal-cortical synchrony

🧬 SST 🏥 alzheimers 📖 66🏛 2

✅ 0.88 ✨ 0.78 💥 0.80

## Mechanistic Overview...

therapeutic 0.89

APOE-Dependent Autophagy Restoration

🧬 MTOR 🏥 neurodegeneration 📖 56🏛 3

✅ 0.90 ✨ 0.60 💥 0.80

## Mechanistic Overview...

therapeutic 0.88

Beta-frequency entrainment therapy targeting PV interneuron-astrocyte coupling for tau clearance

🧬 SST 🏥 alzheimers 📖 57🏛 2

✅ 0.85 ✨ 0.82 💥 0.82

## Mechanistic Overview...

therapeutic 0.88

Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation

🧬 HCRTR1/HCRTR2 🏥 neurodegeneration 📖 37🏛 2

✅ 0.90 ✨ 0.75 💥 0.80

## Mechanistic Overview...

therapeutic 0.87

Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhythmogenesis and block tau AIS disruption i

🧬 PVALB 🏥 alzheimers 📖 64🏛 2

✅ 0.86 ✨ 0.79 💥 0.80

## Mechanistic Overview...

therapeutic 0.87

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via direct PV interneuron recruitm

🧬 PVALB 🏥 alzheimers 📖 68🏛 3

✅ 0.82 ✨ 0.78 💥 0.75

## Mechanistic Overview...

therapeutic 0.87

Optogenetic restoration of hippocampal gamma oscillations via selective PV interneuron activation using implantable LED

🧬 PVALB 🏥 alzheimers 📖 68🏛 3

✅ 0.45 ✨ 0.78 💥 0.68

## Mechanistic Overview...

therapeutic 0.86

Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-gamma coupling and prevent tau seeding i

🧬 PVALB 🏥 alzheimers 📖 67🏛 3

✅ 0.45 ✨ 0.85 💥 0.75

## Mechanistic Overview...

therapeutic 0.85

Senescent Cell ASM-Complement Cascade Intervention

🧬 SMPD1 🏥 neurodegeneration 📖 54🏛 1

✅ 0.68 ✨ 0.78 💥 0.75

## Mechanistic Overview...

therapeutic 0.84

Neutral Sphingomyelinase-2 Inhibition for Synaptic Protection in Neurodegeneration

🧬 SMPD3 🏥 neurodegeneration 📖 45🏛 1

✅ 0.68 ✨ 0.78 💥 0.75

## Mechanistic Overview...

therapeutic 0.83

AMPK hypersensitivity in astrocytes creates enhanced mitochondrial rescue responses

🧬 PRKAA1 🏥 neurodegeneration 📖 45🏛 2

✅ 0.85 ✨ 0.80 💥 0.75

## Mechanistic Overview...

therapeutic 0.83

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymphatic enhancement and amy

🧬 PVALB 🏥 alzheimers 📖 65🏛 2

✅ 0.55 ✨ 0.82 💥 0.78

## Mechanistic Overview...

therapeutic 0.83

Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST interneurons to restore hippocampal-prefronta

🧬 SST 🏥 alzheimers 📖 50🏛 3

✅ 0.35 ✨ 0.82 💥 0.78

## Mechanistic Overview...

therapeutic 0.82

miR-33 Antisense Oligonucleotide Hyper-Lipidation Strategy

🧬 miR-33/ABCA1 🏥 molecular-biology 📖 8🏛 1

✅ 0.51 ✨ 0.70 💥 0.65

## Mechanistic Overview...

therapeutic 0.82

Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservation

🧬 BDNF 🏥 alzheimers 📖 77🏛 2

✅ 0.72 ✨ 0.68 💥 0.78

## Mechanistic Overview...

therapeutic 0.82

CYP46A1 Small Molecule Activator Therapy

🧬 CYP46A1 🏥 neurodegeneration 📖 47🏛 3

✅ 0.75 ✨ 0.71 💥 0.76

This approach employs pharmacological activation of endogenous CYP46A1 rather than gene overexpression to treat Alzheimer's disease through enhanced b...

therapeutic 0.82

CYP46A1-Mediated Cholesterol Reduction Prevents eIF2α-Driven Translation Stalling in Neurodegeneration

🧬 CYP46A1 🏥 neurodegeneration 📖 47🏛 3

✅ 0.75 ✨ 0.71 💥 0.76

This hypothesis proposes that CYP46A1 overexpression gene therapy prevents neurodegeneration by disrupting the pathological link between cholesterol d...

therapeutic 0.81

Extracellular Vesicle Biogenesis Modulation

🧬 CHMP4B 🏥 neurodegeneration 📖 29🏛 1

✅ 0.35 ✨ 0.63 💥 0.00

## Mechanistic Overview...

therapeutic 0.81

Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and block tau propagation via perforant path i

🧬 PVALB 🏥 alzheimers 📖 58🏛 3

✅ 0.78 ✨ 0.76 💥 0.75

## Mechanistic Overview...

therapeutic 0.81

LRP1-Dependent Tau Uptake Disruption

🧬 LRP1 🏥 neurodegeneration 📖 23🏛 1

✅ 0.29 ✨ 0.35 💥 0.00

## Mechanistic Overview...

therapeutic 0.81

Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone Deficiency to Neuroinflammation

🧬 HCAR2 🏥 neurodegeneration 📖 11🏛 1

✅ 0.82 ✨ 0.70 💥 0.75

## Mechanistic Overview...

therapeutic 0.81

Neutrophil Extracellular Trap (NET) Inhibition

🧬 PADI4 🏥 N/A 📖 10🏛 1

✅ 0.00 ✨ 0.41 💥 0.00

## Mechanistic Overview...

therapeutic 0.80

Targeted Butyrate Supplementation for Microglial Phenotype Modulation

🧬 GPR109A 🏥 neurodegeneration 📖 29🏛 3

✅ 0.90 ✨ 0.60 💥 0.80

## Mechanistic Overview...

therapeutic 0.80

Dual-Receptor Antibody Shuttling

🧬 N/A 🏥 alzheimers 📖 10🏛 1

✅ 0.55 ✨ 0.34 💥 0.00

## Mechanistic Overview...

therapeutic 0.80

Microglial TREM2-SYK Pathway Enhancement

🧬 TREM2 🏥 neurodegeneration 📖 8🏛 2

✅ 0.70 ✨ 0.60 💥 0.80

## Mechanistic Overview...

therapeutic 0.80

Closed-loop transcranial focused ultrasound targeting CA1 PV interneurons with real-time gamma feedback to prevent tau p

🧬 PVALB 🏥 alzheimers 📖 50🏛 2

✅ 0.35 ✨ 0.92 💥 0.78

## Mechanistic Overview...

therapeutic 0.79

Senescent Microglia Resolution via Maresins-Senolytics Combination

🧬 BCL2L1 🏥 neurodegeneration 📖 25🏛 2

✅ 0.70 ✨ 0.80 💥 0.80

## Mechanistic Overview...